Light Horse Therapeutics: Funding, Investors & Team (Oct 2026)
Light Horse Therapeutics is utilizing gene editing in order to discover small-molecule drugs that target the underlying causes of severe and life-threatening illnesses. Their cutting-edge technology identifies hidden functional areas within disease-related targets, particularly focusing on challenging oncology targets. They plan to expand the use of this technology to other areas of therapy in the future.
Light Horse Therapeutics has raised $62.0M across 1 funding round on record, the most recent a Series A of $62.0M announced in Jan 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Light Horse Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Light Horse Therapeutics Funding Rounds
Light Horse Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Light Horse Therapeutics Funding Compared to Other Biotechnology Startups
Light Horse Therapeutics' latest round of $62.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Light Horse Therapeutics in Biotechnology and San Diego
Companies Similar to Light Horse Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Light Horse Therapeutics Funding FAQs
What does Light Horse Therapeutics do?
Light Horse Therapeutics is utilizing gene editing in order to discover small-molecule drugs that target the underlying causes of severe and life-threatening illnesses. Their cutting-edge technology identifies hidden functional areas within disease-related targets, particularly focusing on challenging oncology targets. They plan to expand the use of this technology to other areas of therapy in the future.
How much funding has Light Horse Therapeutics raised?
Light Horse Therapeutics has raised $62.0M across 1 round on record. The most recent is a Series A of $62.0M announced in Jan 2025.
When did Light Horse Therapeutics last raise funding?
Light Horse Therapeutics' most recent funding round on record is a Series A of $62.0M, announced in Jan 2025.
Who founded Light Horse Therapeutics?
FundedIQ lists Ben Cravatt (Founder) at Light Horse Therapeutics.
Where is Light Horse Therapeutics headquartered?
Light Horse Therapeutics is based in San Diego, California, United States.
How many employees does Light Horse Therapeutics have?
Light Horse Therapeutics is in the 11-50 employee band.
How does Light Horse Therapeutics' funding compare to other Biotechnology startups?
Light Horse Therapeutics' latest round of $62.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Light Horse Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Light Horse Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.